11:25 AM EDT, 08/26/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts edged lower late Monday morning, declining 0.12% to 1,470.85 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech ( EVAX ) and semiconductor company Sequans Communications ( SQNS ) , which rose 3.8% and 3.5% respectively. They were followed by biotech firm BioNTech (BNTX) and telecommunications operator Telefonica ( TEF ) , which were up 1.4% and 1.1% respectively.

The decliners from continental Europe were led by medical device maker EDAP (EDAP) and biopharmaceutical company DBV Technologies ( DBVT ) , which dropped 6.4% and 4.2% respectively. They were followed by furniture maker Natuzzi (NTZ) and internet browser company Opera (OPRA), which fell 3.9% and 3% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which increased 5.8% and 5.4% respectively. They were followed by software firm Endava ( DAVA ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which were up 1.7% each.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and biotech firm Autolus Therapeutics ( AUTL ) , which fell 5.1% and 3% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and TC Biopharm ( TCBP ) , which were down 2.6% and 1.5% respectively.